{
    "exam_type": "EQE",
    "year": "2021",
    "exam_name": "PreEx",
    "exercices": [
        {
            "question_number": "1",
            "question_type": "True/False",
            "context": "The European patent application EP-A was filed on 07 September 2017.  The mention of grant of the patent was published in the European Patent  Bulletin on 10 February 2021. The applicant validly filed a divisional  application from EP-A (EP-A-DIV) on 05 February 2021.      For each of the statements 1.1 \u2013 1.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "The renewal fee for EP-A in respect of the third year could have been validly paid on 03 May 2019.",
                    "answer": "True",
                    "examiner_note": "\u2013 the renewal fee in respect of the third year (only) may be validly paid up to 6 months before it falls due (30 September 2019), Rule 51(1) EPC; Guidelines A-X 5.2.4, OJ EPO 2018 A2 (effective from 01 April 2018)."
                },
                {
                    "question_code": "2",
                    "question_text": "The renewal fee for EP-A in respect of the fourth year was due on 07 September 2020.",
                    "answer": "False",
                    "examiner_note": "\u2013 the renewal fee for the fourth year is due on the last day of the month containing the third anniversary of filing (i.e. 30 September 2020), (Article 86 EPC, R51(1) EPC)."
                },
                {
                    "question_code": "3",
                    "question_text": "The renewal fee for EP-A in respect of the fifth year shall be paid to the EPO.",
                    "answer": "False",
                    "examiner_note": "\u2013 the obligation to pay renewal fees (to the EPO) shall terminate with the payment of the renewal fee due in respect of the year in which the mention of the grant of the European Patent is published in the European Patent Bulletin (Article 86(2) EPC; Article 141(1) EPC; GL 2018 A-X, 5.1.2) i.e. the renewal fee in respect of the fifth year is due 30 September 2021; the patent is granted before this date and therefore, the renewal fee is paid to national offices."
                },
                {
                    "question_code": "4",
                    "question_text": "All renewal fees due in respect of EP-A-DIV can be validly paid without an additional fee on 07 June 2021.",
                    "answer": "True",
                    "examiner_note": "\u2013 all renewal fees already due in respect of the earlier application at the date on which the divisional application is filed are due on filing (i.e. the renewal in respect of the 3rd year and the 4th year for EP-A, due on 30 Sept 2019 and 30 Sept 2020). These fees and any renewal fee due within 4 months of filing the divisional may be paid within the same 4 months i.e. 07 June 2021 (05 June 2021 is a Saturday, so that the time limit is extended to 07June 2021) without an additional fee (Rule 51(3) EPC); the deadline may be extended under Rule 134 (1) EPC to the next working day (J4/91)."
                }
            ]
        },
        {
            "question_number": "2",
            "question_type": "True/False",
            "context": "Anna, a French citizen, validly filed a French patent application FR-1 on  06 February 2020. On 08 February 2021 she filed an international  application PCT-1 in respect of the same subject-matter as FR-1 at the  EPO. Anna intends for PCT-1 to claim priority from FR-1.      For each of the statements 2.1 \u2013 2.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "PCT-1 can validly claim priority from FR-1.",
                    "answer": "True",
                    "examiner_note": "- Priority can be claimed in an international application filed within 12 months from the priority date (Art. 8(2)a) and Rule 4 PCT, Art. 4C(1) Paris Convention). The applicant and the subject matter is the same. The last day of the 12-month period is 6. February 2021 according to the calculation of periods in Rule 2.4 PCT. Since the 6. February 2021 is a Saturday, the time limit is extended to the next working day (8. February 2021) according to R. 80.5 PCT."
                },
                {
                    "question_code": "2",
                    "question_text": "Anna can validly file the priority declaration in May 2021.",
                    "answer": "True",
                    "examiner_note": "- The priority declaration can be added within a time limit of 16 months from the priority date (which would expire on 7 June 2021, since the 6 June 2021 is a Sunday). Rule 26.bis PCT."
                },
                {
                    "question_code": "3",
                    "question_text": "PCT-1 cannot validly claim priority from FR-1, if FR-1 has been abandoned before the filing of PCT-1.",
                    "answer": "False",
                    "examiner_note": "- Once the priority application has a filing date, the fate of the priority application is not relevant for the priority claim (Art. 8.2(a) PCT and Art 4A(3) Paris Convention)."
                },
                {
                    "question_code": "4",
                    "question_text": "The filing fee for PCT-1 shall be paid directly to the International Bureau.",
                    "answer": "False",
                    "examiner_note": "-The filing fee shall be paid within one month from the date of receipt of PCT-1 to the receiving Office. Rule 15.1 and 15.3 PCT."
                }
            ]
        },
        {
            "question_number": "3",
            "question_type": "True/False",
            "context": "European patent application EP-P was filed as a first filing on 16  December 2018. EP-P was published on 17 June 2020. Application EP-  P-DIV1 was filed with the EPO on 06 December 2019 as a divisional  application from EP-P. A second divisional application from EP-P (EP-P-  DIV2) was filed with the EPO on 06 November 2020. Today, EP-P is still  pending. Some of the claims of EP-P-DIV2 contain subject-matter that  was not originally disclosed in EP-P.      For each of the statements 3.1 \u2013 3.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "EP-P-DIV1 was not validly filed as a divisional application of EP-P, because EP-P-DIV1 was filed before the publication of EP-P.",
                    "answer": "False",
                    "examiner_note": "The earlier patent application must be pending (Rule 36(1) EPC). There is no requirement that the earlier patent application is published."
                },
                {
                    "question_code": "2",
                    "question_text": "If EP-P was filed in Portuguese and translated into English, EP-P- DIV1 must be filed in English.",
                    "answer": "False",
                    "examiner_note": "EP-DIV1 may be filed in the language on which the earlier application was filed (Portuguese) or translated (English)( Rule 36(2) EPC)."
                },
                {
                    "question_code": "3",
                    "question_text": "For EP-P-DIV2 an additional fee as part of the filing fee for a divisional application of a second generation had to be paid.",
                    "answer": "False",
                    "examiner_note": "- EP-DIV2, as it derives from EP-P, is not a second generation divisional application. Thus, an additional fee in accordance with R. 38(4) EPC and Art. 2(1b) RRF has not to be paid."
                },
                {
                    "question_code": "4",
                    "question_text": "EP-P will be regarded as prior art under Art. 54(2) EPC against EP- P-DIV2.",
                    "answer": "False",
                    "examiner_note": "\u2013 According to Article 76(1) EPC, the date of filing is that of the earlier application. Even if EP-DIV2 contains subject-matter extending beyond the content of the earlier application as originally filed, it cannot be converted to an independent application taking 6 November 2020 as its date of filing (G1/05 and G1/06, GL C-IX, 1.4). Therefore, the filing date of EP-DIV2 remains 16 December 2018 and EP-P is not prior art under Art. 54(2) EPC."
                }
            ]
        },
        {
            "question_number": "4",
            "question_type": "True/False",
            "context": "Applicant A files today, 01 March 2021, an international application, PCT-  A, with the EPO. PCT-A claims priority from the applicant\u2019s European  patent application, EP-A, filed on 27 February 2020.  For each of the statements 4.1 \u2013 4.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "If PCT-A contains 20 claims, claims fees shall be paid for five claims within one month of the date of filing.",
                    "answer": "False",
                    "examiner_note": "\u2013 There is no claims fee for PCT applications. A claims fee is not foreseen in PCT (Art. 3(4)(iv) and Rules 14-16 PCT)."
                },
                {
                    "question_code": "2",
                    "question_text": "The period for entering the European phase will expire on 02 October 2023.",
                    "answer": "False",
                    "examiner_note": "- The time limit is 31-months from the priority date, i.e. 27.9.2022 (Art. 22(1) PCT and R. 159(1) EPC)."
                },
                {
                    "question_code": "3",
                    "question_text": "The publication date of PCT-A can be postponed, if the claim to priority is validly withdrawn before completion of the technical preparations for international publication.",
                    "answer": "True",
                    "examiner_note": "- R. 90bis.3 (d) and (e) PCT allows the postponement of the international publication by withdrawing its claim for priority."
                },
                {
                    "question_code": "4",
                    "question_text": "For PCT-A to be considered as comprised in the state of the art under Article 54(3) EPC, it is sufficient that PCT-A is published in English.",
                    "answer": "False",
                    "examiner_note": "\u2013 In order that PCT-A is comprised in the art under Article 54(3) EPC, the requirements of Article 153(5) together with Rule 165 EPC have to be met so that also the filing fee under Rule 159(1)(c) EPC has to be paid."
                }
            ]
        },
        {
            "question_number": "5",
            "question_type": "True/False",
            "context": "The mention of the grant of the European patent EP-G was published in  the European Patent Bulletin. Competitor B filed a notice of opposition  against EP-G on the last day of the opposition period.  One month after expiry of the opposition period and following a request  from the proprietor of EP-G to competitor Z to cease alleged  infringement, competitor Z instituted proceedings for a ruling that  competitor Z is not infringing patent EP-G.      For each of the statements 5.1 \u2013 5.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "If the notice of opposition has not been signed by the opponent or by his representative before expiry of the opposition period, the opposition division shall reject the opposition as inadmissible.",
                    "answer": "False",
                    "examiner_note": "- Rule 76(3) EPC in conjunction with Rule 50(3)EPC require that the notice of opposition is signed by the opponent or the opponent\u2019s representative. If the notice of opposition has not been signed within the opposition period, the EPO will invite the opponent to correct this deficiency and if the opponent does not correct this deficiency within the specified time limit, the opposition is deemed not to have been filed. (Rule 77(2) EPC in conjunction with Rule 50(3) EPC, Guidelines D-III, 3.4 and D-IV, 1.2.1 (ii) and D-IV, 1.4.1."
                },
                {
                    "question_code": "2",
                    "question_text": "Competitor B shall file a statement setting out for the first time the grounds of opposition within two months from the date of filing the notice of opposition.",
                    "answer": "False",
                    "examiner_note": "- The notice of opposition shall contain the grounds on which the opposition is based and has to be filed within 9 months of the mention of the publication of the mention of the grant of the EP patent (Article 99(1) and Rule 76(2)(c) EPC)."
                },
                {
                    "question_code": "3",
                    "question_text": "Provided that the opposition proceedings are still pending, competitor Z can file an admissible notice of intervention within three months of the date on which the proceedings for a ruling that competitor Z is not infringing patent EP-G are instituted.",
                    "answer": "True",
                    "examiner_note": "- Article 105(1)(b) EPC in conjunction with Rule 89(1) EPC."
                },
                {
                    "question_code": "4",
                    "question_text": "If W files third party observations before expiry of the nine-month opposition period, W will be summoned to any oral proceedings taking place before the opposition division. Part 2 of Pre-examination 2021",
                    "answer": "False",
                    "examiner_note": "\u2013 A third party filing observations does not become party to the opposition proceedings (Article 115 EPC last sentence) and, in consequence, W will not be summoned to any oral proceedings (Rule 115(1) EPC). PART 2"
                }
            ]
        },
        {
            "question_number": "6",
            "question_type": "True/False",
            "context": "A European patent application, EP-X, relating to invention X was filed in  January 2020. EP-X includes two alternative embodiments: X1 and X2.  Embodiment X1 is not sufficiently disclosed as essential technical  information is missing. Embodiment X2 is sufficiently disclosed.      For each of the statements 6.1 \u2013 6.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "An objection from the examining division under Article 83 EPC regarding embodiment X1 can be overcome by filing additional technical information.",
                    "answer": "False",
                    "examiner_note": "- The European patent application must disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art (Article 83 EPC)."
                },
                {
                    "question_code": "2",
                    "question_text": "If the examining division does not raise any objection under Article 83 EPC, lack of sufficiency of disclosure will not be a valid ground for opposition against the patent granted on the basis of EP-X.",
                    "answer": "False",
                    "examiner_note": "- A valid ground for opposition is lack of sufficiency of disclosure, Article 100(b) EPC. It is irrelevant if the examining division did not raise an objection under Article 83 EPC."
                },
                {
                    "question_code": "3",
                    "question_text": "If the missing essential technical information regarding embodiment X1 is present in the abstract, the essential technical information can be incorporated into EP-X as missing parts within one month from the date of filing.",
                    "answer": "False",
                    "examiner_note": "- The abstract is not part of the disclosure (Article 85 EPC) so including the essential technical information from the abstract would offend Article 123(2) EPC."
                },
                {
                    "question_code": "4",
                    "question_text": "An objection from the examining division under Article 83 EPC can be overcome by restricting EP-X to embodiment X2.",
                    "answer": "True",
                    "examiner_note": "- If X2 is sufficiently disclosed, a patent may be granted based on X2 (Guidelines F-III, 5.1)."
                }
            ]
        },
        {
            "question_number": "7",
            "question_type": "True/False",
            "context": "The applicant Mr Y filed a European patent application EP-Y. In the  summons to oral proceedings, the examining division objected to claim 1  of EP-Y as not having an inventive step in view of document D1 in  combination with the skilled person\u00b4s common general knowledge.  At the oral proceedings before the examining division, the professional  representative of Mr Y is accompanied by Professor N. The professional  representative requests that Professor N is allowed to make oral  submissions during the oral proceedings. Professor N is a well-known  expert in the technical field of the patent application and has recently  been awarded a Nobel prize for her work in that technical field.  Moreover, Professor N is accompanied by five of her students who also  wish to attend the oral proceedings. Neither the presence of Professor N  nor that of her students had been announced prior to the oral  proceedings.      For each of the statements 7.1 \u2013 7.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "The examining division may admit auxiliary requests filed and signed by Professor N during the oral proceedings.",
                    "answer": "False",
                    "examiner_note": "- Professor N is not the representative of the party Article 134(1) EPC Guidelines, E-III, 8.5, G 4/95)."
                },
                {
                    "question_code": "2",
                    "question_text": "The EPC does not provide for the hearing of witnesses during examination proceedings.",
                    "answer": "False",
                    "examiner_note": "- Article 117 EPC applies to any proceedings before the EPO including examination proceedings so that a witness can be heard during examination proceedings."
                },
                {
                    "question_code": "3",
                    "question_text": "The students of Professor N may attend the oral proceedings as members of the public.",
                    "answer": "False",
                    "examiner_note": "- Article 116(3) EPC: the oral proceedings before the examining division are not public. Therefore, the students of Professor N may not attend the oral proceedings as members of the public."
                },
                {
                    "question_code": "4",
                    "question_text": "Professor N has the right to make oral submissions during the oral proceedings, since she must be considered by the examining division to represent the \u201cperson skilled in the art\u201d.",
                    "answer": "False",
                    "examiner_note": "- The EPC does not provide a right for experts to make oral submissions in representation of the skilled person. The requirements for making oral submissions as accompanying person are set in G4/95 and Guidelines E-III, 8.5."
                }
            ],
            "examiner_note": "The applicant Mr Y filed a European patent application EP-Y. In the summons to oral  proceedings, the examining division objected to claim 1 of EP-Y as not having an inventive step  in view of document D1 in combination with the skilled person\u00b4s common general knowledge.  At the oral proceedings before the examining division, the professional representative of Mr Y  is accompanied by Professor N. The professional representative requests that Professor N is  allowed to make oral submissions during the oral proceedings. Professor N is a well-known  expert in the technical field of the patent application and has recently been awarded a Nobel  prize for her work in that technical field.    Moreover, Professor N is accompanied by five of her students who also wish to attend the oral  proceedings. Neither the presence of Professor N nor that of her students had been  announced prior to the oral proceedings."
        },
        {
            "question_number": "8",
            "question_type": "True/False",
            "context": "European patent EP-C was opposed on the grounds of lack of novelty  and lack of an inventive step. The opposition division rejected the  opposition. The opponent filed an admissible appeal against the decision  of the opposition division. Appeal proceedings concerning European  patent EP-C are currently pending.      For each of the statements 8.1 \u2013 8.4, indicate on the answer sheet  whether the statement is true or false:      A fresh ground of opposition under Article 100(b) EPC can now be  introduced into the appeal procedure\u2026",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "\u2026 since the patent proprietor is party to the appeal proceedings as of right.",
                    "answer": "False",
                    "examiner_note": "\u2013 The criteria for the admissibility of a fresh ground of opposition as set out in G10/91. This situation is not a criteria for the admissibility of a fresh ground for opposition according to G10/91."
                },
                {
                    "question_code": "2",
                    "question_text": "\u2026 provided that the board of appeal considers the ground of opposition as prima facie relevant, even if the patent proprietor does not agree to its introduction.",
                    "answer": "False",
                    "examiner_note": "- Such a fresh ground cannot be introduced by the board of appeal at this stage of the proceedings, even using its powers under Article 114(1) EPC (G10/91)."
                },
                {
                    "question_code": "3",
                    "question_text": "\u2026 provided that the fresh ground is raised by third party observations under Article 115 EPC, even if the patent proprietor does not agree to its introduction.",
                    "answer": "False",
                    "examiner_note": "- The same applies to third party observations under Article 115 EPC as third party observations are also not one of the criteria set out in G10/91."
                },
                {
                    "question_code": "4",
                    "question_text": "\u2026 provided that the fresh ground is raised in an admissible notice of intervention filed during the pending appeal proceedings, even if the patent proprietor does not agree to its introduction.",
                    "answer": "True",
                    "examiner_note": "- According to G1/94, intervention under Article 105 EPC in pending appeal proceedings may be based on any ground for opposition under Article 100 EPC."
                }
            ]
        },
        {
            "question_number": "9",
            "question_type": "True/False",
            "context": "European patent application EP-F has been filed in French and oral  proceedings have been scheduled before the examining division. At the  beginning of the oral proceedings, the professional representative  requests to speak in English without providing for interpretation into  French. He also requests that the minutes be written in English and  declares that he is aware that, if both his requests are permitted, no  interpretation and translation into French will be provided, neither for the  oral proceedings nor for the minutes.      For each of the statements 9.1 \u20139.4, indicate on the answer sheet  whether the statement is true or false:",
            "questions": [
                {
                    "question_code": "1",
                    "question_text": "The examining division may reject the request to speak English in the oral proceedings, even though English is an official language of the EPO.",
                    "answer": "True",
                    "examiner_note": "- The language of the proceedings is French, see Art. 14(3) EPC. Rule 4(1): \u201cAny party to oral proceedings before the European Patent Office may use an official language of the European Patent Office other than the language of the proceedings, if such party gives notice to the European Patent Office at least one month before the date of such oral proceedings or provides for interpretation into the language of the proceedings.\u201d"
                },
                {
                    "question_code": "2",
                    "question_text": "The examining division may agree to the request that the minutes be written in English, except for amendments to EP-F, which will be entered in the minutes in French.",
                    "answer": "True",
                    "examiner_note": "- Statements by employees of the European Patent Office, parties, witnesses or experts, made in an official language of the European Patent Office, shall be entered in the minutes in that language and amendments to a European patent application or European patent shall be entered in the minutes in the language of the proceedings (R. 4(6) EPC and Guidelines E-V, 6)."
                },
                {
                    "question_code": "3",
                    "question_text": "During the oral proceedings, the representative can validly file a new amended set of claims in English.",
                    "answer": "False",
                    "examiner_note": "- Amendments to a European patent application or European patent shall be filed in the language of the proceedings, i.e. French (Rule 3(2) EPC)."
                },
                {
                    "question_code": "4",
                    "question_text": "If the examining division agrees, the representative may make a part of his oral statements during the oral proceedings in Swedish.",
                    "answer": "True",
                    "examiner_note": "- If the parties and the European Patent Office agree, any language may be used (Rule 4(4) EPC. Guidelines E-V, 2)."
                }
            ]
        }
    ]
}